Riverhead Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	$253K	Sell	2,812 -2,554	-48%	-$230K	0.01%	1035
2019 Q2	$453K	Buy	5,366 +5,188	+2,915%	+$438K	0.02%	764
2019 Q1	$16K	Buy	178 +36	+25%	+$3.24K	﹤0.01%	1478
2018 Q4	$10K	Buy	+142	New	+$10K	﹤0.01%	1480